Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.

Background and aims: Medication for opioid use disorder (MOUD) reduces harms associated with opioid use disorder (OUD), including risk of overdose. Understanding how variation in MOUD duration influences overdose risk is important as health‐care payers increasingly remove barriers to treatment conti...

Descripción completa

Detalles Bibliográficos

Publicado en:	Addiction Vol. 117; no. 12; pp. 3079 - 3089
Autores principales:	Burns, Marguerite, Tang, Lu, Chang, Chung‐Chou H., Kim, Joo Yeon, Ahrens, Katherine, Allen, Lindsay, Cunningham, Peter, Gordon, Adam J., Jarlenski, Marian P., Lanier, Paul, Mauk, Rachel, McDuffie, Mary Joan, Mohamoud, Shamis, Talbert, Jeffery, Zivin, Kara, Donohue, Julie
Formato:	research tables/charts Journal Article
Publicado:	Wiley-Blackwell Dec2022
Acceso en línea:	Ver este registro en EBSCOhost